News and Media
;
How AI can help diagnose cancers that are otherwise hard to spot
OICR-supported researchers are harnessing the power of artificial intelligence to help diagnose cancer quickly and accurately. The difference between cancerous and non-cancerous tissue can be so subtle it’s almost imperceptible. And yet distinguishing one from the other can mean the difference between life and death. Early detection is critical to treating cancer effectively, and it’s […]
Read the story
Mar 25, 2024
OICR-supported cancer therapeutics company Fusion Pharmaceuticals acquired by AstraZeneca for $2 billion
Mar 22, 2024
How the Ontario Cancer Research Ethics Board protects participants while streamlining research in the province
Mar 22, 2024
Ask a cancer researcher: Is there a blood test for cancer?
Feb 28, 2024
“Dream team” science helps move Ontario ahead of the curve on hard-to-treat cancers
Feb 27, 2024
Using AI to connect cancer patients with cutting-edge clinical trials
Feb 27, 2024
New PFAC Chair takes lead of growing, evolving community of OICR patient partners
Feb 16, 2024
Ask a cancer researcher: How can Ontarians get tested for hereditary cancers?
Jan 30, 2024
AI helps find new leads for brain cancer drug discovery
Jan 29, 2024
Ask a cancer researcher: What are ‘imaging probes’ and how can they help diagnose prostate cancer?
Jan 25, 2024
Working with racialized communities to improve access to genetic testing
Jan 09, 2024
Newest OICR Investigator seeks to develop precision treatments for young people with high risk leukemia
Jan 02, 2024
Healthy diet linked to reduced risk of colon cancers in men
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.